Literature DB >> 6332733

A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.

S K Law, A W Dodds, R R Porter.   

Abstract

A remarkable difference has been observed between the reactivity of the two forms of human complement component C4. C4B binds twice as effectively as C4A to antibody-coated red cells, but the reverse occurs with protein-antigen complexes. C4B reacts much more effectively with hydroxyl groups than C4A and this is reversed for reaction with amino groups in spite of the very small difference in amino acid sequence between the two forms of C4. No other differences in stability, activation or inactivation were observed. These findings emphasise the biological advantage of the duplication of the C4 gene in its reaction with a wide range of antigenic structures. The correlation of the presence of different forms of C4 with susceptibility to autoimmune diseases may be explicable by these big differences in binding reactivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332733      PMCID: PMC557602          DOI: 10.1002/j.1460-2075.1984.tb02052.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4).

Authors:  R E Hall; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

2.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Human C4-binding protein: N-terminal amino acid sequence analysis and limited proteolysis by trypsin.

Authors:  K B Reid; J Gagnon
Journal:  FEBS Lett       Date:  1982-01-11       Impact factor: 4.124

Review 4.  The proteolytic activation systems of complement.

Authors:  K B Reid; R R Porter
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

5.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Fourth component of human complement: studies of an amine-sensitive site comprised of a thiol component.

Authors:  J Janatova; B F Tack
Journal:  Biochemistry       Date:  1981-04-28       Impact factor: 3.162

7.  The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

Authors:  J W Goers; R R Porter
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

8.  The binding of human complement component C4 to antibody-antigen aggregates.

Authors:  R D Campbell; A W Dodds; R R Porter
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

9.  Purification and structural analysis of the fourth component of human complement.

Authors:  C Bolotin; S Morris; B Tack; J Prahl
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

10.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  93 in total

1.  Analysis of human C4A and C4B binding to an immune complex in serum.

Authors:  B D Reilly
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

2.  Increased frequency of complement C4B deficiency in rheumatoid arthritis.

Authors:  William F C Rigby; Yee Ling Wu; Moe Zan; Bi Zhou; Sanna Rosengren; Cheryl Carlson; Whitney Hilton; C Yung Yu
Journal:  Arthritis Rheum       Date:  2012-05

3.  A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.

Authors:  M B Fasano; J A Winkelstein; T LaRosa; W B Bias; R H McLean
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

Authors:  C W van den Berg; P Démant; P C Aerts; H Van Dijk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

5.  Assessment of complement C4 gene copy number using the paralog ratio test.

Authors:  Michelle M A Fernando; Lora Boteva; David L Morris; Bi Zhou; Yee Ling Wu; Marja-Liisa Lokki; Chack Yung Yu; John D Rioux; Edward J Hollox; Timothy J Vyse
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

Review 6.  Complement-dependent transport of antigen into B cell follicles.

Authors:  Santiago F Gonzalez; Veronika Lukacs-Kornek; Michael P Kuligowski; Lisa A Pitcher; Søren E Degn; Shannon J Turley; Michael C Carroll
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

7.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 8.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

9.  Unequal expression of complement C4A and C4B genes in rheumatoid synovial cells, human monocytoid and hepatoma-derived cell lines.

Authors:  A Falus; J Kramer; E Walcz; Z Varga; J Setalo; K Jobst; T Lakatos; K Merétey
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

10.  Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.

Authors:  A Sepp; A W Dodds; M J Anderson; R D Campbell; A C Willis; S K Law
Journal:  Protein Sci       Date:  1993-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.